Publicaciones en colaboración con investigadores/as de Queen Mary University of London (9)

2024

  1. Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach

    Cell death & disease, Vol. 15, Núm. 2, pp. 127

2023

  1. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells

    Science advances, Vol. 9, Núm. 42, pp. eadi0244

2021

  1. Brafv600e mutant allele frequency (Maf) influences melanoma clinicopathologic characteristics

    Cancers, Vol. 13, Núm. 20

  2. Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification

    Acta Dermato-Venereologica, Vol. 101, Núm. 11

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 6, pp. 1210-1217

  2. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2019

  1. T-type Cav3.1 channels mediate progression and chemotherapeutic resistance in glioblastoma

    Cancer Research, Vol. 79, Núm. 8, pp. 1857-1868

2008

  1. Unregulated smooth-muscle myosin in human intestinal neoplasia

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 14, pp. 5513-5518